What LTS contributes

LTS leads the way in transdermal therapy systems (LTS TTS) and oral thin films (LTS OTF). As a B2B partner to the pharmaceutical industry, we offer solutions at all stages of drug development: from feasibility assessments, research and development of new formulations to clinical trials (up to phase II), production and packaging.

 

Learn more about …

Patches – an attractive niche in the pharmaceuticals market

With sales of around €4.9 billion, the transdermal therapeutic system (TTS) market makes up a very small part of this. Nevertheless TTS are an attractive niche in the global pharmaceuticals market.

 

Learn more about …

Good reasons for choosing LTS

The path from the developed substance to the successful transdermal therapeutic system (TTS) or oral thin film (OTF) is a long and labour-intensive one. As such, you need a strong, experienced and commited partner at your side. LTS as the market leader fulfils all these requirements.

 

Learn more about …

LTS as a partner for healthcare innovations

LTS covers in a single source all the relevant technical steps in drug development – from feasibility studies for your drug up to the market launch and subsequent large scale manufacturing. LTS manufactures for the global markets of your choice – make use of our expertise as an innovative market leader.

 

Learn more about …